| Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy |
Globe Newswire |
09/08 |
08:30 |
| Draganfly Selected for All Five Capability Streams of Canada’s New Defence Drone Initiative Marketplace |
Globe Newswire |
09/08 |
08:30 |
| MediaValet Launches Custom Homepage, Giving Every DAM User a Personalized Home from Day One |
Globe Newswire |
09/08 |
08:30 |
| Liberty Defense Previews the HEXWAVE I-Configuration at GSX 2026 for Entrances That Cannot Give Up a Lane |
Globe Newswire |
09/08 |
08:30 |
| Dynagas LNG Partners LP Reports Results for the Three and Six Months Ended June 30, 2026 |
Globe Newswire |
09/08 |
08:30 |
| HYCU® Brings Enterprise-Class Data Protection to Azure DevOps with General Availability of HYCU R-Cloud™ for Azure DevOps |
Globe Newswire |
09/08 |
08:30 |
| Axel Merk Calls on ASA Board to Give Shareholders Liquidity at Nav Before Saba BDC Conversion |
Globe Newswire |
09/08 |
08:30 |
| Sparrow Pharmaceuticals Appoints George Eldridge as Chief Financial Officer |
Globe Newswire |
09/08 |
08:30 |
| Orion Announces Additional Multimillion-Dollar Data Center Engagement With Major Global Hyperscaler; Order Quickly Follows Inaugural Multimillion-Dollar Initiative |
Globe Newswire |
09/08 |
08:28 |
| Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study |
Globe Newswire |
09/08 |
08:20 |
| Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial |
Globe Newswire |
09/08 |
08:17 |
| Worthington Enterprises Schedules Fiscal First Quarter 2027 Earnings Call for September 23 |
Globe Newswire |
09/08 |
08:15 |
| Confused.com Partners with HUMAN Security to Protect Digital Customer Journeys in the Agentic Era |
Globe Newswire |
09/08 |
08:12 |
| BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema |
Globe Newswire |
09/08 |
08:00 |
| American EcoFuels Inc. (OTC: AEFI) Appoints Samson Lee, John Gerdin and Niclas von Schantz to Board of Directors |
Globe Newswire |
09/08 |
08:00 |
| 1606 Corp. and EthosEnergy O&M Execute LOI for Operations and Maintenance of Lufkin Power Facility For Data Centers |
Globe Newswire |
09/08 |
08:00 |
| Frontier Power USA Announces Appointment of World-Class Leadership Team to Scale U.S. Long-Duration Energy Storage |
Globe Newswire |
09/08 |
08:00 |
| QNB Corp. Announces the Execution of a Strategic Repositioning |
Globe Newswire |
09/08 |
08:00 |
| Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director |
Globe Newswire |
09/08 |
08:00 |
| Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure |
Globe Newswire |
09/08 |
08:00 |
| DotKonnekt Expands Kompass Studio to Give Enterprises AI Sovereignty |
Globe Newswire |
09/08 |
08:00 |
| Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3 |
Globe Newswire |
09/08 |
08:00 |
| FTC Solar Begins Shipments on 330 MW Fraser Coast Project in Australia |
Globe Newswire |
09/08 |
08:00 |
| Uniti Wholesale Boosts U.S.-Mexico and Southwest Data Center Connectivity |
Globe Newswire |
09/08 |
08:00 |
| Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference |
Globe Newswire |
09/08 |
08:00 |
